OutSee Raises $2.4 Million in Seed Funding

Rare Daily Staff

OutSee, a genomics and drug discovery company pioneering an AI-based predictive genomics approach to target discovery, said it raised $2.4 million (£1.8 million) in seed funding.

Ahren Innovation Capital led the round with additional investment from Kadmos Capital, Empirical Ventures, and Panacea Ventures.

The company said the funds will support it through the next phase of its growth strategy, with a focus on expanding its in-house target discovery program and establishing new strategic partnerships with pharma and biotech companies.

OutSee’s proprietary Nomaly technology predicts disease and phenotype directly from a single genome. Unlike other methods commonly used for target discovery, the AI-powered engine uses hypothesis-free, predictive modelling to draw conclusions from the genome’s fundamental molecular and cellular biology rather than pattern-matching known genetic associations.

The genomics-first approach enables Nomaly to complement existing target discovery pipelines, uncovering underlying biological mechanisms that drive and modulate disease. Nomaly can be applied to small datasets, or to unlock new, actionable insights from data that have already been analyzed, helping to advance therapeutic discovery and development. The technology has been developed for use across a broad range of application areas, with OutSee’s in-house program initially focused on CNS, rare, and metabolic disease.

OutSee has previously received more than $680,000 (£500,000) in precision medicine grants from the United Kingdom’s national innovation agency, Innovate UK, to support technology extensions and to test their application on dementia case studies.

“OutSee’s Nomaly technology is a truly next-generation genomic analysis tool with potential to transform drug discovery using powerful data-driven insights. It allows us to interrogate smaller datasets, and even data that have already been analyzed, to uncover unique target insights that until now would have remained undetected,” said Julian Gough, CEO and Founder of OutSee.

Photo: Julian Gough, CEO and Founder of OutSee